PATENT CLAIM ANALYSIS

Application Number: 16020291
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "300000"]

Abstract:
This disclosure relates to methods of diagnosing and treating small cell lung cancer. In certain embodiments, this disclosure relates to methods of treating small cell lung cancer comprising administering an effective amount of a polo-like kinase 1 (PLK-1) inhibitor to a subject in need thereof. In certain embodiments, the subject is diagnosed with small cell lung cancer.

Claim (Index 3):
The method of  claim 1 , wherein the subject previously received a first chemotherapy treatment.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15431312', '14607732', '13806929', '11490438', '14450068']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7465997507684449
- 35 USC 102 Novelty (BERT): 0.4982253579365954
- Combined Prediction Score: 0.7217623114852599
- Mean Citation Score: 233.85396
- Max Citation Score: 252.83531
- Similarity Product: 196.076570763824

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test